as on January 10, 2026 at 2:29 am IST
Day's Low
Day's High
0.12%
Downside
3.50%
Upside
52 Week's Low
52 Week's High
42.30%
Downside
6.49%
Upside
Check Haemonetics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.0B
EPS (TTM)
4.9141
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.23%
PE Ratio (TTM)
24.57
Industry PE ratio
7.264444444444444
PEG Ratio
1.2691
EBITDA
360.3M
Revenue (TTM)
1.3B
Profit Margin
12.67%
Return On Equity TTM
19.47%
Track how Haemonetics Corp P/E has moved over time to understand its valuation trends.
Haemonetics Corp in the last 5 years
Lowest (13.82x)
December 31, 2025
Industry (7.26x)
January 10, 2026
Today (24.57x)
January 10, 2026
Highest (52.66x)
March 31, 2021
Today’s Price to Earnings Ratio: 24.57x
Compare market cap, revenue, PE, and other key metrics of Haemonetics Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $4.0B | -35.95% | 24.57 | 12.67% | |
| BUY | $145.8B | 165.69% | 52.61 | 14.43% | |
| BUY | $140.4B | 50.84% | 48.32 | 12.07% | |
| BUY | $126.6B | -18.53% | 26.75 | 13.71% | |
| BUY | $219.6B | 12.82% | 15.85 | 31.88% |
The Haemonetics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Haemonetics Corp investment value today
Current value as on today
₹1,11,013
Returns
₹11,013
(+11.01%)
Returns from Haemonetics Corp Stock
₹6,952 (+6.95%)
Dollar Returns*
₹4,061 (+4.06%)
Based on 11 analysts
72.73%
Buy
27.27%
Hold
0.00%
Sell
Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Haemonetics Corp. Average target price of $90.2
Get share price movements and forecasts by analysts on Haemonetics Corp.
What analysts predicted
9.09%UPSIDE
Target Price
$90.2
Current Price
$82
Analyzed by
11 Analysts
Target
$90.20
Haemonetics Corp target price $90.2, a slight upside of 9.09% compared to current price of $82. According to 11 analysts rating.
Search interest for Haemonetics Corp Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 34.03M → 38.68M (in $), with an average increase of 12.0% per quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 321.39M → 327.31M (in $), with an average increase of 1.8% per quarter
Price Rise
![]()
In the last 3 months, HAE stock has moved up by 67.9%
Against Peers
![]()
In the last 3 years, Boston Scientific Corp. has given 21.4% return, outperforming this stock by 22.5%
Against Peers
![]()
In the last 1 year, Medtronic Plc has given 20.9% return, outperforming this stock by 13.9%
| Organisation | Haemonetics Corp |
| Headquarters | 125 Summer Street, Boston, MA, United States, 02110 |
| Industry | Health Technology |
| CEO | Mr. Christopher A. Simon |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. James C. D'Arecca CPA | CFO, Executive VP & Financial Officer |
Ms. Michelle L. Basil Esq., J.D. | Executive VP, General Counsel & Secretary |
Ms. Olga Guyette | Senior Director of Investor Relations |
Mr. Rajeev Varma | Senior Vice President of Strategy & Corporate Development |
Ms. Laurie A. Miller | Senior VP & Chief Human Resources Officer |
Mr. Christopher A. Simon | CEO, President & Director |
Mr. Frank W. Chan Ph.D. | Executive VP & COO |
Ms. Farris Maryanne Maunsell | VP, Chief Accounting Officer & Principal Accounting Officer |
Dr. Jan Hartmann M.D. | Senior VP & Chief Medical Officer |
Mr. Roy Galvin | Executive VP & Chief Commercial Officer |
Haemonetics Corp share price today is $82 as on at the close of the market. Haemonetics Corp share today touched a day high of $84.87 and a low of $81.9.
Haemonetics Corp share touched a 52 week high of $87.32 on and a 52 week low of $47.32 on . Haemonetics Corp stock price today i.e. is closed at $82,which is 6.09% down from its 52 week high and 73.31% up from its 52 week low.
Haemonetics Corp market capitalisation is $0.00T as on .
Indian investors can start investing in Haemonetics Corp (HAE) shares with as little as ₹90.17 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹901.70 in Haemonetics Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Haemonetics Corp share’s latest price of $82 as on January 10, 2026 at 2:29 am IST, you will get 0.1220 shares of Haemonetics Corp. Learn more about
fractional shares .
Haemonetics Corp stock has given -35.95% share price returns and 22.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?